AIMS FELLOWSHIP CURRICULUM TS 3 TRANSFUSION SCIENCE Reference Laboratory Immunohaematology. Reference Laboratory Immunohaematology
|
|
- Katrina Gaines
- 6 years ago
- Views:
Transcription
1 Module Code: TS 3 Module Title: Module Convenor: Discipline Committee: Dr T Cobain SEALS Executive Unit Level 4 Campus Centre The Prince of Wales Hospital Baker St, Randwick, NSW, 2031 Ms Dianne Grey Dr D Roxby Ms D Stern Date Module Outline last reviewed: January 2016 Date Module Outline last modified January
2 A. Objectives This Module is designed to provide the candidate with a sound working knowledge of Transfusion Science as it pertains to the transfusion support of patients, and the investigation of immunohaematological states in a Reference Immunohaematology Laboratory. The Module assumes a basic knowledge of immunohaematological techniques and principles. B. Interrelationship of the Module to Other Modules This Module provides the basis for immunohaematological principles relating to reference laboratory immunohaematology and builds on the immunohaematological investigations covered in TS1. Module TS 1 Core Module: Patient Based Transfusion Science C. Brief Description This Module will provide a sound working knowledge of the immunohaematological principles for the operation of an immunohaematology reference laboratory. D. Content 1. Platelet Antigens and Antibodies 1.1 The genetic basis for platelet HPA-antigens including their gene frequencies. 1.2 The techniques used for HPA-antigen typing. 1.3 The techniques used for the detection of platelet antibodies. 1.4 The clinical consequences of platelet antibody formation, investigation protocols and the principles of treatment for the following clinical settings: a) Foeto-maternal alloimmune thrombocytopenia, b) Platelet transfusion support. c) Autoimmune thrombocytopenias,. d) Post transfusion purpura. 1.5 Drug associated antibodies and their detection. Objective: To understand the techniques and protocols used for platelet antigen and antibody detection and the clinical consequences. 2. Granulocyte Antigens and Antibodies 2.1 The genetic basis for granulocyte antigens including their gene frequencies. 2.2 The techniques used for granulocyte antigen typing.
3 2.3 The techniques used for the detection of granulocyte antibodies. 2.4 The clinical consequences of granulocyte antibody formation. Objective: To understand the techniques used for granulocyte antigen and antibody detection and the clinical consequences. 3 Well Characterised Independent Blood Group Antigens The names and ISBT code numbers of the independent high incidence antigens currently associated with the 901 series. 3.2 The names and ISBT code numbers of the independent low incidence antigens currently associated with the 700 series. Objective: To be familiar with antigens of high and low incidence which are not currently associated with a blood group system. ABO Subgroups and H- deficient Blood Groups 4.1 The serological properties and methodologies used to identify ABO subgroups and H-deficient phenotypes. Objective: To recognise ABO subgroups and H-deficient phenotypes 5 The Complexities of the Rh System 5.1 The molecular biology of the Rh system including Variants of RhD, Weak D, Rh null and Rh mod. 5.2 Low incidence Rh antigens associated with red cells that carry partial D. 5.3 Clinical aspects of the Rh system including the role of molecular genotyping. Objective: To have an understanding of the Rh complex. To be familiar with low incidence antigens associated with partial D. 6 High Titre Low Avidity Antibodies 6.1 The genetic basis for so called HTLA antigens ( Ch/Rg, Knops system, Yk a /Csa, JMH ) including their gene frequencies. 6.2 The principles and technical requirements of current methodologies and procedures used for the identification of HTLA antibodies. 6.3 Clinical significance of HTLA antibodies.
4 Objective: To be thoroughly familiar with the characteristics of HTLA antibodies and the techniques used for identification. 7 Race-related and Other Red Cell Antigens and Alloantibodies 7.1 Then genetic, molecular and biochemical basis for the high and low frequency antigens of the MNSs system and the serological properties of corresponding antibodies. 7.2 Antibodies to high incidence and low incidence antigens in different ethnic backgrounds. Genetic background of red cell null phenotypes in Lu, Ge, Fy, Jk, MNSs, Kell, Cr, Do systems. 7.3 Biological and clinical consequences of red cell null phenotypes, including Kx. 7.4 Implications for transfusion (including sickle cell disease). 7.5 The properties of the antigens and antibodies of the Yt, Do, Di, Co and Cr systems and the clinical significance of the antibodies. 7.6 Polyagglutination and associated antigens. Objective: To be familiar with the high and low incidence antigens associated with established blood group systems and their antibodies, including those found in different ethnic backgrounds and associated with null phenotypes. Awareness of the transfusion, clinical and biological implications. Familiarity with T/Tn system cryptantigens and mechanisms effecting their exposure. 8 Identification of Novel Red Cell Antigens 8.1 The serological (including enzymes and chemical modifications) and molecular techniques available for use in identifying a novel red cell antigen. 8.2 Understanding of the ISBT terminology for Red Cell surface Antigens Objective: To be thoroughly familiar with the process of identifying novel red cell antigens. E Rationale for Content A comprehensive understanding of the scientific principles required for a reference immunohaematology laboratory. F Examination Examination will focus on an overall understanding of the scientific basis of reference immunohaematology laboratory.
5 Under the Fellowship Regulations, a 3-hour written examination will be held at the completion of this Module. The examination will contain a mixture of short answer questions and essay style questions..clinical and laboratory case based scenarios may be included in the question mix. Examination for this Module will focus on an overall understanding of the principles and procedures across the major topic themes : Platelet Antigens and Antibodies Granulocyte Antigens and Antibodies ABO Subgroups and H- deficient Blood Group Systems Complexities of the Rh System High titre low Avidity Antibodies Race related and other red cell antigens and alloantibodies Identification of novel red cell antigens The examination will consist of: 10 short answer questions (5 minutes each total 50 minutes) 5 assay style questions (20 minutes each total 100 minutes) Questions will be divided across the topic themes. The unallocated 30 minutes of the exam period should be devoted to carefully reading the questions and reflecting on your response. G. Texts and Supporting Material The following texts and articles are recommended. In addition current volumes of the recommended journals should be consulted for relevant articles. 1 Issitt PD, Anstee DJ. Applied Blood Group Serology. Montgomery Scientific Publications 4 th Edition Klein HG, Anstee DJ. Molllisons Blood Transfusion in Clinical Medicine. 11 th Edition Technical Manual American Association of Blood banks current Edition 4 Metcalfe P. Platelet antigens and antibody detection. Vox. Sang. 2004; 87: (Suppl 1) S Stroncek D, Granulocyte antigen and antibody detection. Vox. Sang. 2004; 87: (Suppl 1), S Recommended Journals:
6 Transfusion Vox Sanguinis including ISBT Science Series Transfusion Medicine Transfusion Medicine Reviews Immunohaematology H. Appointment of a Mentor Each candidate is required to nominate a mentor for the Module at the time of application for entry and into the Fellowship Program. If a candidate is unable to nominate a mentor then the candidate should contact the Module Convenor for assistance. The appointment of a mentor is made by the Examinations Council. I. Module Communications Module Convenor: Dr T Cobain trevor.cobain@health.nsw.gov.au Discipline Committee: Ms Dianne Grey Dr D Roxby Ms D Stern J. Candidate Feedback Immediately following notification of the examination result each candidate will be asked to complete a feedback questionnaire on the Module. However, feedback at anytime during the study of the Module is encouraged through the mentor or directly to the Module Convenor.
Georgia Spanos, MT LifeSouth Community Blood Centers Gainesville, Fl. SEABB March 2017
Georgia Spanos, MT LifeSouth Community Blood Centers Gainesville, Fl. SEABB March 2017 Case Study 1 Patient Demographics -44 year old -African-American Female -Diagnosis: Gastroenteritis -Facility reported
More informationCase Report: Atypical Presentation of Anti-Rg a
100 Case Report: Atypical Presentation of Anti-Rg a Eiad Kahwash, Sameer S.Talwalkar, Jill Leonard, and William Lockwood Department of Pathology and Laboratory Medicine, University of Louisville, Louisville,
More informationImmunohematology Case Studies PD Dr. med. Franz F Wagner Red Cross Blood Service NSTOB
Immunohematology Case Studies 2016-5 PD Dr. med. Franz F Wagner Red Cross Blood Service NSTOB fwagner@bsd-nstob.de Clinical History A 78 yrs old patient had coronary artery bypass surgery. In the perioperative
More informationWe are actually talking about the Rh Blood Group System!
hr Problems Is this a discussion of your Human Resources nightmares? We are actually talking about the Rh Blood Group System! hr Problems 1 Hr and hr Antigens Hr o (Rh17) Hr or Hr S (Rh18) Hr B (Rh34)
More informationUse and Abuse of Reagents and Techniques. Joann Moulds PhD, MT(ASCP)SBB Director, Scientific Support Services LifeShare Blood Centers Shreveport, LA.
Use and Abuse of Reagents and Techniques Joann Moulds PhD, MT(ASCP)SBB Director, Scientific Support Services LifeShare Blood Centers Shreveport, LA. Antibody Screening & Identification Blood Grouping Reference
More informationImmunohematology Practicum Objectives - CLS 645
Clinical Laboratory Sciences Department University of Kansas Medical Center Immunohematology Practicum Objectives - CLS 645 The following objectives are to be completed by the student for successful completion
More informationDIAGNOSTIC SERVICES BC & YUKON
DIAGNOSTIC SERVICES BC & YUKON YEAR IN REVIEW JANUARY - DECEMBER 31, 2012 Page 1 of 23 CANADIAN BLOOD SERVICES BC & YUKON DIAGNOSTIC SERVICES SENIOR STAFF AND CONTACT INFORMATION Medical Director (604)
More informationPractical Aspects and Typing Strategy in Molecular ABO and RH Blood Group Diagnosis
East West Immunogenetics Conference Prague, Czech Republic March 5 6, 2009 Practical Aspects and Typing Strategy in Molecular ABO and RH Blood Group Diagnosis M a r t i n a P r a g e r prager.martina@bag-healthcare.com
More informationINTERNATIONAL SPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2 & 3)
PART I (TO BE COMPLETED BY APPLICANT) Applicant s Name Address Email Address PART II (MUST BE COMPLETED AND SIGNED BY LABORATORY MANAGEMENT* OR EMPLOYER IN ORDER TO BE ACCEPTABLE) SUBJECT: VERIFICATION
More informationSPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2, 3, & 4)
PART I (TO BE COMPLETED BY APPLICANT) Applicant s Name Last Four Digits of Applicant s Social Security # Address Email Address Daytime Telephone Number PART II (MUST BE COMPLETED AND SIGNED BY THE IMMEDIATE
More informationPlatelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD
Platelet Refractoriness: The Basics Martin H. Bluth, MD, PhD Complete Toxicology Laboratories, LLC Objectives Define platelet refractoriness and associated conditions that may cause platelet refractoriness.
More informationMechanisms of extravascular destruction of red cells coated with IgG1 or IgG3 (± C3b).
Introduction - Antibodies involved in transfusion reactions are of two types, namely the complete and the incomplete. - whereas the complete antibodies agglutinate red cells in saline medium, the incomplete
More informationFORENSIC SEROLOGY. Chapter PRENTICE HALL 2008 Pearson Education, Inc. Upper Saddle River, NJ 07458
Chapter 8 FORENSIC SEROLOGY 8-1 Nature of Blood The word blood refers to a highly complex mixture of cells, enzymes, proteins, and inorganic substances. Plasma, which is the fluid portion of blood, is
More informationAntibody Identification: Art or Science? A Case Study Approach
Antibody Identification: Art or Science? A Case Study Approach (Questions and Answers) Editors Janis R. Hamilton, MS, MT(ASCP)SBB Susan T. Johnson, MSTM, MT(ASCP)SBB Sally V. Rudmann, PhD, MT(ASCP)SBB
More informationSerological Testing: Why we did what we did!
Serological Testing: Why we did what we did! W. John Judd, FIBMS, MIBiol Emeritus Professor University of Michigan What we did Provided blood and blood products in a timely, cost-efficient manner. Implemented
More informationDARATUMUMAB HARD TO PRONOUNCE - EVEN HARDER ON BLOOD BANK TESTING. Dr. Jennifer Duncan Hematopathology Resident March 18, 2017
DARATUMUMAB HARD TO PRONOUNCE - EVEN HARDER ON BLOOD BANK TESTING Dr. Jennifer Duncan Hematopathology Resident March 18, 2017 Goals and Objectives: Briefly describe the use of dara in the treatment of
More informationDo Donors With Non-Deletional Blood Group O Allels Boost Anti-A and Anti-B Titers in Blood Group O Recipients?
Do Donors With Non-Deletional Blood Group O Allels Boost Anti-A and Anti-B Titers in Blood Group O Recipients? E. A. Scharberg, S. Seyboth, K. Panter, A. Ernst, J. Hagel, E. Richter, G. Rink, K. Janetzko,
More informationORIGINAL ARTICLE. The persistence of red cell alloantibodies. Roberto Reverberi
ORIGINAL ARTICLE The persistence of red cell alloantibodies Roberto Reverberi Servizio di Immunoematologia e Trasfusionale Cesare Menini, Arcispedale S.Anna, Azienda Ospedaliera - Universitaria di Ferrara,
More informationSerological Tools For Investigating Problems In Immunohaematology
Serological Tools For Investigating Problems In Immunohaematology Dr.K.Vasantha Deputy Director (Retd.) National Institute of Immunohaematology (ICMR) Parel, Mumbai Immunohaematology is an application
More informatione-grips Module 18 Introduction to Antibody Identification
Introduction to Antibody Identification Introduction Objectives After completing the learning module, the learner will be able to: 1. Discuss the limitations of antibody detection and identification. 2.
More informationGUIDELINES for PRETRANSFUSION LABORATORY PRACTICE
Australian & New Zealand Society of Blood Transfusion Ltd 5 th Edition, March 2007 GUIDELINES for PRETRANSFUSION LABORATORY PRACTICE i Copyright by The Australian & New Zealand Society of Blood Transfusion
More informationWhen, autoimmune hemolytic anemia
IMMUNOHEMATOLOGY Adsorption of autoantibodies in the presence of LISS to detect alloantibodies underlying warm autoantibodies Jacques Chiaroni, Mohammed Touinssi, Magali Mazet, Philippe de Micco, and Virginie
More informationHandouts 4/5/2016. BCA Members willing to genotype your samples on Immucor PreciseType HEA
BCA Members willing to genotype your samples on Immucor PreciseType HEA Community Blood Center - Dayton Blood Bank of Delmarva Indiana Blood Center LifeServe Blood Center LifeShare Blood Centers LifeSouth
More informationGUIDELINES FOR PRETRANSFUSION TESTING : PART I
Commissie voor Klinische Biologie Commission de Biologie Clinique GUIDELINES FOR PRETRANSFUSION TESTING : PART I Dr. A. Vanhonsebrouck, Bloedtransfusiecentrum Antwerpen 26-03-2009 WIV congress Rue Juliette
More informationThe Bloodgen project : Platform Technology for Mass Scale Genotyping of Blood Groups and Beyond. Prof. Neil D. Avent and Bloodgen consortium members
The Bloodgen project : Platform Technology for Mass Scale Genotyping of Blood Groups and Beyond Prof. Neil D. Avent and Bloodgen consortium members DGTI Symposium SY1 Friday 24 th September 2004 Bloodgen
More informationReagent Red Blood Cells 0.8% Surgiscreen For the Detection of Unexpected Blood Group Antibodies Using the ID-Micro Typing System Gel Test Methods
Reagent Red Blood Cells 0.8% Surgiscreen For the Detection of Unexpected Blood Group Antibodies Using the ID-Micro Typing System Gel Test Methods Revised October 2015 REF 6902316 Rx ONLY SUMMARY AND EXPLANATION
More informationRed cell alloantibodies
17 Identification of Alloantibodies to Red Cell Antigens Red cell alloantibodies other than non-red-cell-stimulated anti-a or -B are called unexpected red cell alloantibodies and may be found in 0.3-38%
More informationFor order enquiries. Telephone Fax For technical information
Sanquin is responsible for safe and efficient blood supply in the Netherlands on a not-for-profit basis. Sanquin also develops and produces pharmaceutical products, conducts high-quality scientific research,
More informationORIGINAL PAPER. Introduction
ORIGINAL PAPER Vox Sanguinis (2011) ª 2011 The Author(s) Vox Sanguinis ª 2011 International Society of Blood Transfusion DOI: 10.1111/j.1423-0410.2011.01507.x Prevalence and specificity of red-blood-cell
More informationHigh-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors
ORIGINAL PAPER ª 2011 The Author(s) Vox Sanguinis ª 2011 International Society of Blood Transfusion DOI: 10.1111/j.1423-0410.2011.01542.x High-throughput multiplex PCR genotyping for 35 red blood cell
More informationSubject: CPT/HCPCS Codes Effective for Medi-Cal On or After February 1, 2018
4665 Business Center Drive Fairfield, California 94534 Date: 3/19/18 Medi-Cal Important Provider Notice: #310 Subject: CPT/HCPCS Codes Effective for Medi-Cal On or After February 1, 2018 The 2018 updates
More informationSanquin Blood Grouping Reagents
Sanquin Blood Grouping Reagents Blood grouping reagents are essential tools for diagnostic laboratories specialised in serology. The broad range of reagents developed by Sanquin Reagents is used in several
More informationMolecular characterisation of weak Lu a and Lu b expression associated with altered LU*01 and LU*02 alleles
Molecular characterisation of weak Lu a and Lu b expression associated with altered LU*01 and LU*02 alleles Vanja Karamatic Crew 1, Ben Jones 1, Karen DeSay 1, Rosalind Laundy 1, Piers Walser 1, Alan Gray
More informationPaul Ashford Executive Director ICCBBA
Introduction to ISBT 128 Paul Ashford Executive Director ICCBBA ICCBBA ICCBBA enhances safety for patients by managing the ISBT 128 international information standard for use in transfusion and transplantation.
More informationBlood Typing Monoclonal Antibodies. Blood typing intermediates for further manufacturing use
Blood Typing Monoclonal Antibodies Blood typing intermediates for further manufacturing use Merck Millipore, your partner for monoclonal blood typing antibodies For more than 25 years we have been leading
More informationRequirements of IBTO (AABB) Standards d for a Blood Transfusion Request 1.Positive identification of the recipient and the recipient blood samples.
Detection and Identification of alloantibodies to Red Cell Antigens Antibody Screen Test Iranian Blood Transfusion Organization Mostafa Moghaddam MS, CLS ( ASCP ) BB Head of Immunohematology Reference
More informationJaundiced Baby. Introduction to the Patient-Oriented Problem-Solving (POPS) System
Jaundiced Baby Developed by Larry J. McCumber, PhD Parker A. Small, Jr, MD Department of Immunology and Medical Microbiology College of Medicine University of Florida Gainesville, Florida Modified by G.
More informationPRETRANSFUSION OR COMPATIBILITY TESTING
13 PRETRANSFUSION OR COMPATIBILITY TESTING 13.1 INTRODUCTION Pretransfusion compatibility testing serves to select a compatible unit of blood for the recipient which when transfused does not cause any
More informationClassification under the IVD Regulation
Classification under the IVD Regulation Nick Baker Head of IVD Notified Body LRQA Ltd Improving performance, reducing risk IVD regulation shift in regulatory scrutiny Under the current IVD directive 10-15%
More informationGuidelines for compatibility procedures in blood transfusion laboratories
Transfusion Medicine, 2004, 14, 59 73 GUIDELINES Guidelines for compatibility procedures in blood transfusion laboratories Working Party of the British Committee for Standards in Haematology Blood Transfusion
More informationSTANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA
STANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA TITLE: STANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA 1.0 Principle 1.1 The purpose of quality control
More informationLaboratory: Document Type: Original Date Adopted: Previous Document: Transfusion Services Procedure 04/01/02 TRB-9 Revision 4
Laboratory: Document Type: Original Date Adopted: Previous Document: Transfusion Services Procedure 04/01/02 TRB-9 Revision 4 Document Author: Document Owner: Acknowledgement / Required Copy Holders*:
More informationComponent Preparation, Manufacturing and Modifications
Component Preparation, Manufacturing and Modifications Mahdokht Parsi, MPH, MT(ASCP) Director of Operation, Immunohematology & Genomics Mparsi@nybc.org Current Practices in Transfusion Medicine 1 NEW YORK
More informationIntroduction to Pharmacogenetics Competency
Introduction to Pharmacogenetics Competency Updated on 6/2015 Pre-test Question # 1 Pharmacogenetics is the study of how genetic variations affect drug response a) True b) False Pre-test Question # 2 Pharmacogenetic
More informationCarol A Starks MS, MLS(ASCP), CLS. castarks
Carol A Starks MS, MLS(ASCP), CLS Brief review of the common blood groups ABO Rh Kell Duffy Kidd P Lutheran MNS Lewis Basic Blood Bank workups ABO discrepancies Single antibody not demonstrating Single
More informationRh Molecular Testing
Rh Molecular Testing Future Webinars October 31 December 6 HLA: Transfusion and Transplant Running a Remote Transfusion Service Link to register: https://immucor.webinato.com/register All Content 2015
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 22 February 2006 EMEA/CHMP/BMWP/42832/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON SIMILAR
More informationFunction, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking
Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking Joy Gould BB(ASCP)C, SBB, CQIA(ASQ), CPHQ Thomas Jefferson University Hospital Philadelphia, PA Objectives Define Multiple
More informationHeparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.
Heparin Induced Eric Kraut, MD Professor of Internal Medicine The Ohio State University Medical Center Heparin Induced Heparin induced thrombocytopenia occurs in up to 5 % of patients receiving unfractionated
More informationOriginal Equipment Manufacturing. Intermediate and OEM Products for Immunohaematology
Original Equipment Manufacturing Intermediate and OEM Products for Immunohaematology A long history as an OEM manufacturer For over 30 years, Quotient has developed, manufactured and marketed high quality
More informationAnnals of Alquds Medicine (٢٠٠٩) Issue ٥ : ١٨-٢٧
Original Article RHD Gene Polymorphism among Palestinians of Gaza Strip. Dawoud M.I. 1, Shubair M.E. 2, Sharif F.A. 2* 1. Al-Shifa Hospital, Central Blood Bank, Gaza. 2. Medical Technology Department,
More informationGUIDELINES FOR ISSUING AND RETURNING BLOOD COMPONENTS AND BLOOD PRODUCTS WITHIN A FACILITY
GUIDELINES FOR ISSUING AND RETURNING BLOOD COMPONENTS AND BLOOD PRODUCTS WITHIN A FACILITY 1. Policy Statement 1.1 A policy shall be in place to ensure traceability of all blood components and blood products
More informationBlood Grouping Reagent IH-Card Group ABO A-B-A-B-A-B
Blood Grouping Reagent IH-Card Group ABO A-B-A-B-A-B English, B186363, Version 06, 2017.03 FOR IN VITRO DIAGNOSTIC USE Gel card for use with the IH-System MEETS FDA POTENCY REQUIREMENTS U.S. LICENSE NUMBER:
More informationABO Typing Discrepancies
Jayme Heimonen MT(ASCP)SBB Blood Bank Technical Specialist Borgess Medical Center Kalamazoo, MI ASCLS-Michigan 2016 1 Expected reactions are missing 4+ 0 4+ 0 0 0 0 0 4+ 0 0 3+ 2 Unexpected reactions are
More informationDTT Treated Reagent Red Cells for use in Resolving DARA Interference. More Than Just Kell?? Marilyn Stewart MT(ASCP)SBB
DTT Treated Reagent Red Cells for use in Resolving DARA Interference More Than Just Kell?? Marilyn Stewart MT(ASCP)SBB Daratumumab Anti-myeloma and anti-lymphoma agent known to interfere with routine Blood
More informationNHSBT Portfolio of Blood Components and Guidance for their Clinical Use. Summary of Significant Changes. Purpose. Definitions. Applicable Documents
This Specification replaces SPN223/7 Copy Number Effective: 21/12/16 Summary of Significant Changes Introduction of HEV testing, and Pooled Platelets in Plasma/Additive mixture Amendment to interruption
More informationUnderstanding DARZALEX Interference With Blood Compatibility Testing
Understanding DARZALEX Interference With Blood Compatibility Testing DARZALEX (daratumumab) Results in a False Positive Indirect Coombs Test DARZALEX is a human monoclonal antibody for the treatment of
More informationHistocompatibility. Revised and effective July 14, Histocompatibility Standard 1 (HC S1)
Clinical Laboratory s of Practice The following specialty sustaining standards of practices shall be incorporated into the laboratory s quality management system, where applicable to the scope of services
More informationReflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development
1 2 3 24 June 2010 EMA/CHMP/641298/2008 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug
More informationFunction, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking
Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking Joy Gould BB(ASCP)C, SBB, CQIA(ASQ), CPHQ Thomas Jefferson University Hospital Philadelphia, PA Objectives Define Multiple
More informationBachelor of Science (Hons) / Bachelor of Science Biomedical Science
Bachelor of Science (Hons) / Bachelor of Science Biomedical Science Awarded by In collaboration with This degree course is designed to give you a broad understanding of the scientific investigation of
More informationGUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS
GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS 1. Introduction 1.1 This document provides guidance notes for the assessment of academic qualifications that have not been formally accredited
More informationSTANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION - TUBE METHOD
STANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION - TUBE METHOD TITLE: STANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION TUBE METHOD 1.0 Principle An antibody identification procedure is
More informationKey changes in new BCSH Transfusion I.T. Guidelines. Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group
Key changes in new BCSH Transfusion I.T. Guidelines Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group Membership Joan Jones Head of Quality, Welsh Blood Service Paul Ashford
More informationICH Topic E16 Genomic Biomarkers Related to Drug Response: Context, Structure and Format of Qualification Submissions. Step 3
European Medicines Agency June 2009 EMEA/CHMP/ICH/380636/2009 ICH Topic E16 Genomic Biomarkers Related to Drug Response: Context, Structure and Format of Qualification Submissions Step 3 NOTE FOR GUIDANCE
More informationWHO Biological Standards And. Genetic Reference Materials
WHO Biological Standards And Genetic Reference Materials Elaine Gray and Paul Metcalfe Genetic Reference Materials Gene Medicine Group National Institute for Biological Standards and Control United Kingdom
More informationDiscussion. Principle. Laboratory Procedure Manual EXERCISE 3. Blaney, Chapter 4 The ABO and H Blood Group Systems. Textbook: 20 points.
Exercise 3 ABO and D Typing Textbook: Blaney, Chapter 4 The ABO and H Blood Group Systems Skills: 20 points Objectives 1. Explain why the ABO blood groups are the most significant of all blood group systems.
More informationIMMUNOHEMATOLOGY. The molecular basis of the Rhesus antigen E w
Blackwell Science, LtdOxford, UKTRFTransfusion0041-11322004 American Association of Blood BanksMarch 2004443Original ArticleMOLECULAR BASIS OF THE RHESUS ANTIGEN EWSTROBEL ET AL. IMMUNOHEMATOLOGY The molecular
More informationDNA Typing of the Human MN and Ss Blood Group Antigens in Amniotic Fluid and Following Massive Transfusion
COAGULATION AND TRANSFUSION MEDICINE DNA Typing of the Human MN and Ss Blood Group Antigens in Amniotic Fluid and Following Massive Transfusion JAMES R. ESHLEMAN, MD, PHD, SUSAN H. SHAKIN-ESHLEMAN, MD,
More informationSummer 2007 IN A DIFFERENT VEIN
Michigan Association of Blood Banks presents Summer 2007 IN A DIFFERENT VEIN Michigan Association of Blood Banks, c/o Lisa Tyzo, 29832 Buckingham, Livonia MI 48154 www.mabb.org MABB_lisa@yahoo.com 734-422-3630
More informationCorrespondence should be addressed to Dietmar Enko;
Blood Transfusion, Article ID 532919, 5 pages http://dx.doi.org/10.1155/2014/532919 Research Article Frequencies and Specificities of Enzyme-Only Detected Erythrocyte Alloantibodies in Patients Hospitalized
More informationForecast diagnostics for antimicrobial resistance (AMR)
Forecast diagnostics for antimicrobial resistance (AMR) Authors: Ann Van den Bruel, Philip Turner NIHR Diagnostic Evidence Cooperative Oxford, University of Oxford Context When asked to make forecasts
More informationMulti-centre evaluation of pre-transfusional routine tests using 8-column format gel cards (DG Gel )
Transfusion Medicine, 2011, 21, 90 98 doi: 10.1111/j.1365-3148.2010.01054.x ORIGINAL ARTICLE Multi-centre evaluation of pre-transfusional routine tests using 8-column format gel cards (DG Gel ) J. Taylor,
More informationTable of Contents. Preface... xv. Editorial Comments... xvii. About the Authors... xix
Preface................................................................... xv Editorial Comments........................................................ xvii About the Authors..........................................................
More informationDISTRIBUTION OF ABO GENOTYPES AND ALLELE FREQUENCIES IN A KOREAN POPULATION
Jpn J Human Genet 42, 331-335, 1997 DISTRIBUTION OF ABO GENOTYPES AND ALLELE FREQUENCIES IN A KOREAN POPULATION Sung Ha KANG, x'2 Yasuo FUKUMORI, 1'* Shiro OHNOKI, 1 Hirotoshi SHIBATA, 1 Kyou Sup HAN,
More informationThis position is in the Joint Office of Strategic Planning. This position is for the Medical School Campus.
Planning Associate - Joint Office of Strategic Planning 33673 Washington University School of Medicine in St. Louis MO This position is full-time and works approximately 40 hours per week. Department Name/Job
More informationhttp://www.simonmawer.com/mendel's_garden.jpg 1 http://khzs.fme.vutbr.cz/iahrwg2009/img/map_cz.gif 2 http://www.haverford.edu/biology/meneely/brno.htm 3 http://biology.clc.uc.edu/fankhauser/travel/berlin/for_web/
More informationVII. Rh Blood Group System
VII. Rh Blood Group System A. The Rh system is one of the most complex genetic systems, and certain aspects of its genetics, nomenclature and antigenic interactions are unsettled. The aim of this lecture
More informationSmall Interfering RNA s Molecular biology and use in therapy
Small Interfering RNA s Molecular biology and use in therapy Dr Stuart Hamilton - NHMRC Early Career Fellow Serology and Virology Division, SEALS Microbiology, Prince of Wales Hospital; School of Women
More informationMLAB IMMUNOHEMATOLOGY
Course Syllabus MLAB 2431- IMMUNOHEMATOLOGY Catalog Description: A study of blood antigens and antibodies. Presents quality control, basic laboratory technique and safety. Includes the principles, procedures
More informationResolve Panel A A Qualitative Test for the Identification of Unexpected Blood Group Antibodies
Revised October 2015 Reagent Red Blood Cells Resolve Panel A A Qualitative Test for the Identification of Unexpected Blood Group Antibodies 719510 Rx ONLY SUMMARY AND EXPLANATION When an unexpected antibody
More informationGuidance for Industry and FDA Staff. Replacement Reagent and Instrument Family Policy
Guidance for Industry and FDA Staff Replacement Reagent and Instrument Family Policy Document issued on: December 11, 2003 This document supersedes Data for Commercialization of Original Equipment Manufacturers
More informationRevised Immunogenicity Guideline: Assays and methods- Presentation of the draft guideline and introduction of the topics for discussion
Revised Immunogenicity Guideline: Assays and methods- Presentation of the draft guideline and introduction of the topics for discussion Robin Thorpe & Meenu Wadhwa Revised Guideline: Differences from original
More informationDepartment of Research Evaluation. Biology and pharmacology of blood platelets: haemostasis, thrombosis, transfusion
Department of Research Evaluation report on research unit: Biology and pharmacology of blood platelets: haemostasis, thrombosis, transfusion Under the supervision of the following institutions and research
More informationGenomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)
Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome
More informationApplication of Real-Time PCR and Melting Curve Analysis in Rapid Detection of A el and B el Blood Types
Annals of Clinical & Laboratory Science, vol. 35, no. 1, 2005 25 Application of Real-Time PCR and Melting Curve Analysis in Rapid Detection of A el and B el Blood Types Ding-Ping Chen, 1 Ching-Ping Tseng,
More informationStandards of proficiency. Biomedical scientists
Standards of proficiency Biomedical scientists Contents Foreword 1 Introduction 3 Standards of proficiency 7 Foreword We are pleased to present the Health and Care Professions Council s standards of proficiency
More informationQuality Assurance by Liz McChlery
Quality Assurance by Liz McChlery Define QA and Total Quality Management Describe Quality Control Define and distinguish Accuracy and Precision Define a Biological Reference Interval Describe ISO15189
More informationLABORATORY TRAINING LOGBOOK
REGISTRATION TRAINING PORTFOLIO FOR THE IBMS CERTIFICATE OF COMPETENCE LABORATORY TRAINING LOGBOOK Version 4.1 www.ibms.org Trainee record details Registration Training Portfolio Case No: Surname: First
More informationComments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants
Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December
More informationCAP Accreditation Checklists 2017 Edition
CAP Accreditation Checklists 2017 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight
More informationUCL HUMAN RESOURCES DIVISION. UCL Advert Templates
UCL HUMAN RESOURCES DIVISION UCL Advert Templates Helen Brown Page 1 of 18 10 December 2009 CONTENTS Preparing an Advert... 3 Sample Adverts... 5 Academic Vacancy... 5 Administrative and Support Vacancy...
More informationABO Blood Group Discrepancies: Causes And resolution
ABO Blood Group Discrepancies: Causes And resolution Indian journal of tranffusion Medicine Introduction The ABO system contains four major ABO phenotypes: A, B, O and AB. The four phenotypes are determined
More informationKell Blood Group System (KEL) ISBT 006
Kell, Duffy, Kidd Objectives: Kell, Kidd and Duffy Kell and Duffy in 30 minutes you ve got to be Kidd-ing! (Ok, we ll talk about Kidd, too) Jessica Drouillard, SBB(ASCP) CM Heartland Blood Centers, part
More informationMultiple Myeloma Research Foundation 2014 Research Fellow Award Program Guidelines
Multiple Myeloma Research Foundation 2014 Research Fellow Award Program Guidelines Program Description: MULTIPLE MYELOMA RESEARCH FOUNDATION 2014 RESEARCH FELLOW AWARD The Multiple Myeloma Research Foundation
More informationBuilding on the NHLBI Legacy of Hypertension Research:
Building on the NHLBI Legacy of Hypertension Research: Charting Our Future Together Gary H. Gibbons, M.D. Director National Heart, Lung, and Blood Institute AHA Council on Hypertension September 16, 2015
More informationExam MOL3007 Functional Genomics
Faculty of Medicine Department of Cancer Research and Molecular Medicine Exam MOL3007 Functional Genomics Tuesday May 29 th 9.00-13.00 ECTS credits: 7.5 Number of pages (included front-page): 5 Supporting
More informationCONTINUOUS PRACTICAL ASSESSMENT FORM
Department of Radiography Student Name Placement Date Named radiographer CONTINUOUS PRACTICAL ASSESSMENT FORM Current Year/Term Previous placement date / total weeks on this unit type Duration of placement
More informationRare diseases in the 7th EU Framework Programme for Research and Technological Development
Rare diseases in the 7th EU Framework Programme for Research and Technological Development Manuel Hallen, MD Head of Unit Medical & Public Health Research DG Research European Commission 1 The role of
More information